Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 1,527 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,527 | N/A | N/A | N/A | N/A |
| Operating Expenses | 4,068 | 13,688 | 9,399 | 8,531 | 6,445 |
| Operating Income | -2,541 | -13,688 | -9,399 | -8,531 | -6,445 |
| Other Income | 129 | 131 | 122 | 27 | 40 |
| Pre-tax Income | -2,412 | -13,557 | -9,277 | -8,504 | -6,405 |
| Net Income Continuous | -2,412 | -13,557 | -9,277 | -8,504 | -6,405 |
| Net Income | $-2,412 | $-13,557 | $-9,277 | $-8,504 | $-6,405 |
| EPS Basic Total Ops | -13.60 | -86.77 | -60.18 | -74.18 | -55.98 |
| EPS Basic Continuous Ops | -13.50 | -86.37 | -59.89 | -73.85 | -55.88 |
| EPS Diluted Total Ops | -13.60 | -86.77 | -60.18 | -74.18 | -55.98 |
| EPS Diluted Continuous Ops | -13.50 | -86.37 | -59.89 | -73.85 | -55.88 |
| EBITDA(a) | $-2,541 | $-13,677 | $-9,387 | $-8,519 | $-6,434 |